(Q43889879)

English

Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Mamoru Toyofyuku

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michinori Imazu

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kotaro Sumii

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hideya Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yasuhiko Hayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Keiko Hiyama

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Nobuoki Kohno

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

160

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

339-344

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Neointima formation after vascular injury is angiotensin II mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Vascular renin-angiotensin system and vascular protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Endothelial Dysfunction and Collagen Accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Effects of angiotensin converting enzyme inhibition on endothelial vasodilator function in primary human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Molecular basis of human hypertension: role of angiotensinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Linkage of the Angiotensinogen Gene to Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Angiotensinogen as a risk factor for essential hypertension in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Rapid detection of the hypertension-associated Met235-->Thr allele of the human angiotensinogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Cardiac renin-angiotensin system. Molecular and functional aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Upregulation of Angiotensin-Converting Enzyme During the Healing Process After Injury at the Site of Percutaneous Transluminal Coronary Angioplasty in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

A potent genetic risk factor for restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

ACE Polymorphism, a Genetic Predictor of Occlusion After Coronary Angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900592-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(01)00592-5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43889879&oldid=2104177136"